Gene Therapy Revolution: Waskyra Offers Life-Changing Hope for Wiskott-Aldrich Syndrome Patients
A groundbreaking achievement in genetic medicine has emerged as the European Medicines Agency (EMA) recommended approval of Waskyra (etuvetidigene autotemcel), the first gene therapy specifically designed to treat Wiskott-Aldrich syndrome…